Global Bionic Eye Market, By Types (External Eye and Implanted Eye), Technology (Electronic and Mechanical), End Users (Hospitals, Clinics, and Others) – Industry Trends and Forecast to 2031.
Bionic Eye Market Analysis and Size
Vision restoration is a primary application of the bionic eye market, targeting individuals with severe visual impairments or blindness. Bionic eyes function by capturing visual information through an external camera system, processing it, and transmitting electrical signals to an implanted microelectronic array within the eye. These signals stimulate the remaining functional cells in the retina, effectively bypassing damaged or non-functioning cells and restoring visual perception. This technology offers newfound independence and improved quality of life for individuals who were previously reliant on alternative methods for daily tasks.
The global bionic eye market size was valued at USD 266.59 million in 2023 and is projected to reach USD 523.45 million by 2031, with a CAGR of 8.80% during the forecast period of 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024-2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016 - 2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Types (External Eye and Implanted Eye), Technology (Electronic and Mechanical), End Users (Hospitals, Clinics, and Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Second Sight (U.S.), Bionic Vision Technologies (Australia), THE BIONIC EYE (U.K), PIXIUM VISION (France), Integrated Bionic Microsystems Laboratory (U.S.), NIDEK CO., LTD. (Japan), Optobionics Corporation (U.S.), Biomedical Technologies Inc.(U.S.), Monash Vision Group(Australia), Nano Retina (Israel), MetaModal LLC (U.S), NEOSTRATA COMPANY, INC.(U.S.), Berlin Heart(Germay), ABIOMED(U.S.), Zimmer Biomet(U.S.), eSight (Canada), Alpha IMS GmbH (Germany), Intelligent Implants GmbH (Germany), iBIONICS (Canada), and IIP Technologies GmbH (Germany)
|
|
Market Opportunities
|
|
Market Definition
A bionic eye, also known as a retinal prosthesis, is a medical device designed to restore vision in individuals with severe visual impairment or blindness. It typically consists of an external camera system that captures visual information. It is processed and transmitted to an implanted microelectronic array within the eye, stimulating the remaining functional cells in the retina to generate visual perception.
Bionic Eye Market Dynamics
Drivers
- Growing Technological Advancements
Breakthroughs in microelectronics, biotechnology, and materials science enable the development of more sophisticated and reliable bionic eye devices. Miniaturization of components enhances comfort and aesthetics for users, while advancements in image processing algorithms improve the quality and resolution of visual information captured by external cameras. In addition, improvements in wireless communication and power management systems increase the efficiency and usability of bionic eye implants. These advancements expand the potential user base and contribute to the market's growth by driving adoption rates and stimulating further research and development efforts.
- High Supportive Government Initiatives
Governments acknowledge the critical role of vision restoration technologies in enhancing the quality of life for individuals with visual impairments. As such, they allocate funding, grants, and resources to support research and development in this field. Additionally, regulatory bodies may streamline approval processes for bionic eye devices, facilitating faster market entry. These initiatives encourage innovation and bolster investor confidence, leading to increased investment in bionic eye technology companies.
Opportunities
- Growing Aging Population
The risk of developing age-related vision disorders such as macular degeneration and retinitis pigmentosa increases in the aging population. These conditions can lead to severe visual impairments or even blindness. Bionic eye technology offers a promising solution for restoring vision in individuals affected by these age-related eye diseases, thereby addressing a pressing need in an expanding demographic. With the aging population projected to continue growing, the demand for bionic eyes as a means of vision restoration is expected to rise correspondingly, driving market growth and innovation in the field.
- Growing Awareness among Consumers
Expanding healthcare infrastructure plays a pivotal role in driving the bionic eye market forward. As healthcare systems evolve and expand, there is increased accessibility to advanced medical technologies, including bionic eye devices and associated services. This expansion enables more individuals with visual impairments to access diagnosis, treatment, and post-operative care related to bionic eye implantation. Moreover, improved healthcare infrastructure facilitates the training of healthcare professionals in the implantation and maintenance of bionic eye systems, ensuring safer and more efficient adoption of this technology. Ultimately, this broader access to healthcare services enhances the market penetration and adoption rates of bionic eye solutions, driving overall market growth.
Restraints/Challenges
- High Cost Constraints
The expenses encompass various aspects, including the cost of device development, surgical procedures for implantation, and post-operative care. For many patients, especially those without adequate insurance coverage, the financial burden of bionic eye treatment can be prohibitive. In addition, healthcare systems may face budgetary constraints that limit their ability to provide widespread access to these expensive devices.
- Limited Awareness
Many individuals with visual impairments may not be aware of the availability of bionic eye technology as a potential treatment option. Similarly, healthcare professionals, including ophthalmologists and optometrists, may lack knowledge about the latest advancements in bionic eye devices and their suitability for certain patients. This lack of awareness hampers early diagnosis, referral, and adoption of bionic eye technology, resulting in missed opportunities for patients to benefit from vision restoration solutions.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In June 2020, Hong Kong University of Science and Technology (HKUST) announced a groundbreaking achievement: the world's first 3D artificial eye. This innovation surpassed existing bionic eye technology, boasting capabilities that even exceeded those of the human eye. Notably, this development promised to bring advanced vision to humanoid robots and offered renewed hope for individuals with visual impairments
- In January 2022, Bionic Vision Technologies (BVT) achieved a significant milestone as Australia's pioneering Bionic Eye System received FDA designation as a Breakthrough Device. This recognition marked a crucial step toward potential FDA approval, highlighting the system's innovative approach and its potential to revolutionize vision restoration technology
Bionic Eye Market Scope
The market is segmented on the basis of type, technology, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- External Eye
- Implanted Eye
Technology
- Electronic
- Mechanical
End User
- Hospitals
- Clinics
- Others
Bionic Eye Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, type, technology, and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate in the market due to the region boasting a robust infrastructure of healthcare facilities, facilitating the adoption and utilization of advanced medical technologies such as bionic eyes. Major industry players have established a significant presence in North America, driving innovation and market growth. In addition, the increasing prevalence of eye diseases in the population fuels the demand for advanced vision restoration solutions.
The Asia-Pacific is expected to substantial expansion in the market. This growth is attributed to various factors, including increased government initiatives fostering awareness, a surge in medical tourism, burgeoning research endeavors, and the presence of vast untapped markets. Additionally, the region's large population base and escalating demand for high-quality healthcare further contribute to the anticipated growth trajectory of the bionic eye market in the Asia-Pacific.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Bionic Eye Market Analysis
The global bionic eye market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the market are:
- Second Sight (U.S.)
- Bionic Vision Technologies (Australia)
- THE BIONIC EYE (U.K)
- PIXIUM VISION (France)
- Integrated Bionic Microsystems Laboratory (U.S.)
- NIDEK CO., LTD. (Japan)
- Optobionics Corporation (U.S.)
- Biomedical Technologies Inc.(U.S.)
- Monash Vision Group(Australia)
- Nano Retina (Israel)
- MetaModal LLC (U.S)
- NEOSTRATA COMPANY, INC.(U.S.)
- Berlin Heart(Germay)
- ABIOMED(U.S.)
- Zimmer Biomet(U.S.)
- eSight (Canada)
- Alpha IMS GmbH (Germany)
- Intelligent Implants GmbH (Germany)
- iBIONICS (Canada)
- IIP Technologies GmbH (Germany)
SKU-